Sites binding monoiodinated-Bolton-Hunter-reagent-labelled substance P were solubilized from 1-day-oldchick brain membrane by using non-ionic detergents (1 % digitonin/l % n-octyl glucoside) and a high concentration of NaCl (0.5 M). The solubilized preparation retained the pharmacological properties of the high-affinity binding sites found in the native membrane. The high density of specific binding sites (-2 pmol of binding sites/mg of protein) suggests that the chick brain membranes may be a useful source for the purification of the substance P-binding sites.
INTRODUCTION
Substance P (SP) is an undecapeptide (Arg-Pro-LysPro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2) belonging to a family of biologically active peptides (tachykinins) that share a common conserved C-terminal sequence (Ersparmer, 1981) . SP has a broad spectrum of effects which may be mediated through high-affinity receptor sites on peripheral tissues and the central nervous system (Too & Hanley, 1984) .
Despite the large body of information obtained from binding studies in vitro using labelled SP, very little is known of the molecular nature of this receptor. One of the fundamental approaches to the understanding of the biochemistry of the SP receptor is to solubilize it in a functional state, a prerequisite for the purification of the receptor. Earlier attempts by various workers to solubilize the receptor in a functional state have met with some success, although in low yield (Maruyama, 1986; Payan et al., 1986) . In the present paper we report the characterization of a novel enriched source of SPbinding sites and their solubilization in high yield with retention of the pharmacological properties seen in the membrane-bound state. The resulting preparation is stable to freezing and prolonged storage, thus enabling further characterization and purification.
MATERIALS AND METHODS
Monoiodinated Bolton-Hunter reagent was obtained from Amersham International; SP, SK, NK, Phy, Ele, and Kass were purchased either from Bachem or Cambridge Research Biochemicals; bacitracin, soyabean and chicken-egg trypsin inhibitors, benzamidine hydrochloride, leupeptin, chymostatin, PEI, Triton X-100 and Lubrol PX were obtained from Sigma Co.; digitonin was from BDH; CHAPS and deoxycholate were obtained from Pierce Co. GF/B filters were obtained from Whatman Co.
Preparation of '25l-BHSP
Monoiodinated Bolton-Hunter reagent (1 mCi) was flushed with N2 to evaporate off the solvent. A portion (20 ,ul) of a solution (0.2 mg/ml) of substance P in 0.1 Msodium borate, pH 8.5, was then added to the reagent. The reaction was allowed to proceed for 60 min on ice and the mixture subsequently injected on to a C18 ,uBondapak column (Waters). The products were eluted with a linear gradient of from 5 to 95 % acetonitrile in 0.1 % trifluoroacetic acid in 40 min. Aliquots (2 ,ll) of each fraction (1 ml/fraction) were collected and the radioactivity (y-radiation) counted. The radioactivity profile obtained was compared with that of the elution profile of monoiodinated 125I-BHSP. The fractions containing monoiodinated '25l-BHSP were pooled, and mercaptoethanol (5 mM) was added to prevent oxidation of the peptide during storage. The radioligand was used within 2 months after preparation and was stored at -80 'C. The specific radioactivity of the radioligand as shown in each experiment was calculated from the radioactivity after correction for decay. The radiopurity after 2 months was greater than 70 %. Preparation of membranes Chicks (1 day old) were decapitated. The brains (minus cerebella) were rapidly frozen in liquid N2 and stored at -80 'C until use.
To obtain membranes, frozen brains were first thawed in 5 vol. (v/v) of ice-cold Tris/HCl (50 mM, pH 7.5) buffer containing 10 % (w/v) sucrose and proteinase inhibitors (0.01 % bacitracin, 0.002% soya-bean trypsin inhibitor, 0.002 % chicken-egg trypsin inhibitor and 1 mM-benzamidine hydrochloride), followed by several homogenizations with a Brinkman Polytron PT-10 instrument at maximal setting. The homogenates were centrifuged at 1086 g (rav 10.8 cm) for 20 min, and the resulting supernatants were re-centrifuged at 9770 g (ra. 10.8 cm) for another 20 min. The pellets were then resuspended by homogenization at setting 6 on the Vol. 252
Abbreviations used: SP, substance P; SK, substance K; NK, neuromedin K; Phy, physalaemin; Ele, eledoisin; Kass, kassinin; 125I-BHSP, monoiodinated-Bolton-Hunter-reagent-labelled substance P; PEI, polyethyleneimine; PEG, poly(ethylene glycol); NEM, N-ethylmalaeimide;
Polytron for 5 s in 10 vol. (v/v) of Tris/HCl (50 mM, pH 7.5), containing 120 mM-NaCl, 300 mM-KCI, 10 mM-EDTA. The homogenates were incubated on ice for 30 min with occasional agitation and subsequently centrifuged at 40000 g (rav 10.8 cm) for 20 min. The pellets obtained were then resuspended in 10 vol. (v/v) of icecold Tris/HCl (50 mm, pH 7.5) and re-centrifuged at 40 000 g for 20 min. This washing procedure was repeated twice more and the pellets were finally resuspended in 1 vol. (v/v) of ice-cold Tris/HCl (50 mm, pH 7.5). Aliquots (I ml) were centrifuged at 14000 g (4°C) in a Beckman bench-top centrifuge for 20 min. The supernatants were discarded, and the pellets frozen in liquid N2 and stored at -80°C for no longer than 1 month.
Solubilization procedure
Membrane-bound binding sites were solubilized by resuspending the frozen membranes in sodium Tricine (50 mM, pH 7.5, 22°C) to final concentrations at 6-8 mg of protein/ml. The suspensions were preincubated with 10 mM-MnCI2, 0.0020% soya-bean trypsin inhibitor, 0.0020 chicken-egg trypsin inhibitor, 1 mM-benzamidine hydrochloride and 0.5 M-NaCl, for 30 min at 30 'C. The suspension was then placed on ice for 5-10 min before incubating with a combination of detergents (1 00 n-octyl glucoside and 1 % digitonin; protein/detergent ratio, 1: 3, w/w). Solubilization was carried out at 4 'C with constant and gentle agitation for 30 min, and the suspensions were centrifuged at 105 000 g (rav 63.4 cm) for 60 min at 4 'C. The resulting supernatants were collected, pooled, and then subjected to filtration on a 22 ,um-pore-size filter. The filtrates were used for solublebinding-site assay as described below.
Binding assays
Membranes were preincubated with 50 mM-sodium Tricine supplemented with 0.00400 bacitracin, 0.00400 bovine serum albumin, 0.0002% chymostatin, 0.0004 % leupeptin, 10 mM-MnCl2 for 30 min at 22 'C. Unlabelled peptides and 251I-BHSP were then added and the incubations terminated after 30 min at 22 'C by filtration through GF/B filters presoaked in 0.500 PEI (> 3 h at 22°C), followed by four washes with ice-cold sodium Tricine buffer (50 mm, pH 7.5). The filters were then measured for radioactivity with 700 counting efficiency.
Soluble binding sites were assayed similarly at protein concentrations of 0.1-0.6 mg/ml. Protein concentrations were determined by the miniLowry method (Markwell et al., 1978) , after precipitation with 9.20% (w/v) trichloroacetic acid. BSA was used as the standard.
To evaluate the effects of thiol reagent (NEM) and high temperature on the binding of 125I-BHSP to soluble and membrane preparations, the membranes were first thawed in sodium Tricine (pH 7.5, 50 mM), and portions (4-7 mg of protein/ml) were either incubated with NEM (10 mM) at 32 'C for 30 min or boiled for 15 min. The incubations were terminated by centrifugation at 10000 g for 30 min at 4 'C. The pellets were then resuspended in 1 ml of Tris/HCl, pH 7.5 (50 mM) and re-centrifuged for 15 min at 10000 g (22 C). The final pellets were resuspended in 0.6 ml of sodium Tricine, and triplicate 50 ,ul portions were taken for membrane binding. The remaining membrane suspensions were solubilized as described above. 
RESULTS

Pretreatment of filters
Pretreatment of the GF/B filters with 0.500 PEI greatly reduced the non-specific binding of radioligand (2% of added radioactivity as compared with 46% binding in the absence of pretreatment). More importantly, there was no displaceable site on the pretreated filters with a high concentration of unlabelled P (10-4 M). There were no significant differences in the amount of Lee et al. (1981) .
The pH effect on the binding to membrane-bound sites showed a broad optimum between pH 6.5 and 8 (Fig. 3) .
Membrane when extracted with either Triton X-100, Lubrol PX, CHAPS, deoxycholate or cholate at a concentration of 1 % did not show any specific binding to '25l-BHSP. Digitonin or n-octyl glucoside when used individually yielded extracts that bind '25I-BHSP. However, the soluble extracts showed higher specific activities for the binding of '25I-BHSP when the detergents were used as a mixture. The specific binding to the soluble sites remained unchanged even when filtered through a 0.22 gm-pore-size Millipore filter. The potency in displacing specific 1251I-BHSP binding was: 
Effects of bivalent cations of '25I-BHSP binding
With membrane assays the inclusion of bivalent-metal cations was found to increase the amount of specifically bound 125I-BHSP (Fig. 4) . Mn2" was found to be the most potent cation, followed by Mg2", the least potent being Ca2" (all as chloride salts). Effects of guanine and adenine nucleotides The specific binding of 125I-BHSP to both soluble and membrane-bound binding sites was sensitive to the presence of nucleotide (Fig. 5) , with the most potent analogue being guanosine 5'-[/Jy-imido]triphosphate, the non-metabolized analogue of GTP. The adenine nucleotides were much less active. All of the guanine nucleotides at high concentrations were found to abolish specific binding of '25I-BHSP completely. The IC50 (concentration causing 50 % of maximum inhibition) values of these nucleotides were given in Table 1 (Fig. I a) and soluble binding sites (Table 2) . Scatchard plots of these data yielded equilibrium constants of 0.84+ 0.05 nm (n = 4), and 8.0 + 0.7 nm (n = 4), with maximal binding (Bmax) of 183+53 (n = 4) and 1798+354 (n = 4) fmol/mg of protein for the binding to membrane-bound and soluble sites respectively (Figs. 6a and 6b) .
The competitive inhibition of '52l-BHSP by various tachykinins are shown in Table 2 . The potency of inhibition was in the order of (SP > Phy > Kass > Ele > SK > NK. The soluble receptor showed a similar order of potency to the membrane-bound sites (Fig. 7 and Table 2 ). 
DISCUSSION
In the present study we have adopted a methodology which used PEI pretreated filters to trap soluble and membrane-bound binding sites. Different methods have been developed for separating soluble receptor-bound ligand from free ligand. These include gel filtration, equilibrium dialysis, PEG or (NH4)2SO4 precipitation, charcoal separation, affinity adsorption and filtration through PEI-pretreated glass filters (Bruns et al., 1983) . We have examined PEG and alcohol precipitation in addition to filtration through glass filters pretreated with PEI. The latter method was used because it was reliable, rapid, gave low non-specific binding and could be used for comparing the characteristics of 1251I-BHSP binding to these two different preparations directly.
In addition to low temperature, we have included proteinase inhibitors in the preparation of membranes to reduce the possibility of receptor degradation. The combination of proteinase inhibitors used in the binding assays (chymostatin, leupeptin and bacitracin) inhibited the degradation of radioactive SP in this tissue and in others (Lee et al., 1983; Burcher et al., 1986) .
The sites labelled by 125I-BHSP in chick brain membranes displayed binding properties similar to those reported in the mammalian brain (Cascieri et al., 1985; Torrens et al., 1985; Lee et al., 1986) . The binding was time-dependent, reversible, saturable and of high affinity. The competitive inhibition by various tachykinins suggests that the binding was to the 'SP-P' subclass of tachykinin receptor (Lee et al., 1982) . The dissociation constant (Kd) determined from equilibrium studies (0.84 nM) was different from that determined kinetically (0.0039 nM). A similar discrepancy between the Kd as determined kinetically (0.034nM) and that by equilibrium (0.39 nM) studies has been reported previously by others (Torrens et al., 1986) . The origin of the large discrepancy observed in our studies is unclear and may be indicative of a greater preference for the binding of Bolton-Hunter-iodinated SP over native SP. However, the Kd determined from equilibrium studies was similar to that reported by others using authentic [3H]SP (Lee et al., 1983; Perrone et al., 1983) .
A combination of non-ionic (digitonin and octyl glucoside) detergents was found to extract binding sites from the chick brain membrane effectively. Attempts to extract binding sites with either ionic and zwitterionic detergents were unsuccessful, even though as much as 40 % of the membrane proteins were extracted. With the non-ionic detergents we have solubilized binding sites with high specific activities (-1.8 pmol/mg protein), and the preparations were stable with little loss of binding activity when stored at 4 'C. The binding of 125I-BHSP to the solubilized preparations were also time-dependent, reversible and saturable. However, the dissociation constant for the binding was different, at least an order of magnitude less potent than the binding to membranebound sites (Fig. 6) . The order of the potency of inhibition by the three mammalian tachykinins (Maggio, 1985) was identical with that observed with membranebound sites (Table 2 ). Thus solubilization with the combination of these non-ionic detergents did not alter the pharmacological characteristics of the binding sites.
A number of plasma-membrane receptors for hormones, drugs and neurotransmitters are coupled to guanine-nucleotide-regulatory proteins (Spiegel, 1987) . The 'SP-P' subclass of tachykinin receptors is no exception, as it has been shown in a variety of tissues to be coupled to guanine-nucleotide-regulatory proteins (Lee et al., 1983; Too & Hanley, 1984; Maruyama, 1986; Sharma & Musacchio, 1987) . The solubilized 'SP-P'-type binding sites were sensitive to nucleotides (Table 1) , suggesting a direct coupling of guanine-nucleotidebinding proteins to the binding sites in complexes. At present the identity of the nucleotide-binding proteins is unknown. With the successful solubilization in high yield of the binding sites/guanine-nucleotide-binding complexes, it will be possible to isolate and identify the nucleotide binding proteins along with the binding sites.
Pretreatment of the chick brain membrane with NEM dramatically reduced specific binding of 125I-BHSP. Consistent with this observation, the 'SP-P' subtype of tachykinin receptors in other tissues has been shown to be sensitive to a variety of thiol reagents (Sharma & Musacchio, 1987; Too et al., 1988) . These observations suggest the presence of reactive thiol residues located near, or at, the binding sites.
In the present study we have shown that chick brain membranes have high-affinity binding sites for 125-BHSP similar to those observed in mammalian brain membrane. Furthermore, these binding sites have been solubilized with high specific binding activities and retained the basic pharmacological characteristics of the equivalent membrane-bound sites. Thus the protocol used here may permit the solubilization of the 152I-BHSP binding site in functional state and will enable further biochemical characterization and eventual purification.
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